Top Markets
#1 CyberDEX CyberDEX +678.15%
#2 GEKKO GEKKO +22.84%
#3 Harmony Harmony +20.38%
#4 DogBull DogBull +13.32%
#5 The Sandbox The Sandbox +12.75%
#6 DexNet DexNet +12.63%
#7 Backpack Backpack +12.07%
#8 OriginTrail OriginTrail +10.85%
#9 Fake World Assets Fake World Assets +9.48%
#10 龙虾 (Lobster) 龙虾 (Lobster) +9.26%
Coin of the day
CyberDEX CyberDEX
Settings
Language
ENGLISH
Currency
USD
Theme
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rank in Stocks #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Share Price
$97.46
Last synced: 2026-10-02
Market Cap
$168.63B
Change (1 day)
0.77%
Change (1 year)
-27.59%
Country
US
Trade Abbott Laboratories (ABT)

Category

Healthcare
Operating Margin for Abbott Laboratories (ABT)
Operating Margin as of October 2026 TTM: 17.03%
According to Abbott Laboratories latest financial reports and stock price the company's current Operating Margin (TTM) is 17.03%. At the end of 2024 the company had an Operating Margin of 16.27%.
Operating Margin history for Abbott Laboratories from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 17.03% -6.22%
2025 18.16% 11.62%
2024 16.27% 1.43%
2023 16.04% -16.28%
2022 19.16% -10.30%
2021 21.36% 39.70%
2020 15.29% 6.25%
2019 14.39% 14.48%
2018 12.57% 74.58%
2017 7.20% -53.79%
2016 15.58% 7.82%
2015 14.45% 0.35%
2014 14.40% 46.64%
2013 9.82% 95.23%
2012 5.03% -71.44%
2011 17.61% -12.17%
2010 20.05% -6.13%
2009 21.36% 3.59%
2008 20.62% 8.07%
2007 19.08% -1.09%
2006 19.29% -7.30%
2005 20.81% -1.98%
2004 21.23% 40.50%
2003 15.11% -15.21%
2002 17.82% 53.22%
2001 11.63% -52.99%
2000 24.74% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -98.95%
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -98.71%
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -98.74%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
28.09% -98.35%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.